Absci Corporation

Industry

  • Pharmaceuticals
  • Contract Manufacturing Organization
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Synthesis Technologies, Production Processes
    • Drug Discovery Technologies
  • Digital Health
    • Artificial Intelligence

Other Names/Subsidiaries

  • AbSci
  • Denovium
  • Totient
See more in Biomedtracker

Latest on Absci Corporation

In Vivo

Almirall Goes All In On Generative AI

 
• By David Wild

Barcelona-based Almirall SA is deepening its reliance on generative artificial intelligence (GenAI) for drug discovery and development. The company, which specializes in dermatological indications,

In Vivo

Gen AI Companies Shine In Drug Development

 
• By David Wild

In early December, AstraZeneca PLC announced a $247m alliance with generative artificial intelligence biologics development company, AbSci Corp. , to design an antibody against an unnamed oncology

Scrip

Deal Watch: Vanda Buys US, Canadian Rights To J&J’s Ponvory

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Vanda To Pay $100m For Rights To MS The

Scrip

Almirall Enlists Absci’s AI Expertise For Dermatology Drug Discovery

 
• By Mandy Jackson

Who: Almirall/Absci What: Absci will use its generative AI technology to discover drug candidates for two dermatological targets for Almirall. Why: Almirall committed this year to bringing in mor